MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Mechanistic study of PARP9-mediated mitochondrial transfer in regulating dopaminergic neuronal injury and neuroinflammation in Parkinson’s disease

    L. Liao, Z. Zhang (Guangzhou, Guangdong Province, China)

    Objective: To investigate PARP9 expression and localization in PD models, evaluate its effects on dopaminergic neuronal injury and microglial activation, and determine whether PARP9 regulates…
  • 2026 International Congress

    The Global Parkinsons Genetics Program: Expanding the Diversity of Neurological Disorder Data – 2026 Update

    GP2. Global_parkinsons Genetics_program (Bethesda, USA)

    Objective: To broaden the available data for Parkinson's Disease (PD) and related disorders by integrating genetic data from more than 140,000 participants worldwide through genotyping…
  • 2026 International Congress

    Genomic Insights into Parkinson’s Disease: LARGE-PD and PD GENEration Collaboration in El Salvador

    S. Peña Martínez, T. Ascencio, R. de León, I. Mata (SS, El Salvador)

    Objective: To characterize clinical and genetic features of  Parkinson’s disease (PD)  in El Salvador in the PD GENEration and LARGE-PD. Background: Central American populations remain…
  • 2026 International Congress

    Exploring the Relationship Between Insomnia and Autonomic Dysfunction in Parkinson’s Disease: A 1 Year SCOPA-AUT Analysis

    D. Petrosyan, P. Bhaya, P. Coss, S. Horn, E. Vaou, L. Saadatpour (San Antonio, USA)

    Objective: To evaluate the progression of autonomic dysfunction over one year in patients with Parkinson’s disease (PD) with and without comorbid insomnia. Background: Insomnia and…
  • 2026 International Congress

    “Step-by-Step” in Movement Disorders: A Disease-Specific, Multi-Method Integrated Teaching Approach

    W. Wang, D. Dong, W. Wu, C. Cen, L. Luo (Hangzhou, China)

    Objective: To evaluate the effectiveness of a novel “Step-by-Step” teaching round model in improving neurology residents’ knowledge and clinical competency in movement disorders. Background: Movement…
  • 2026 International Congress

    Phenotypic and Genotypic Spectrum of MAPT-associated Parkinsonism in a Multi-ethnic Malaysian Cohort

    JP. Schee, YW. Tay, TS. Toh, AN. Khairul Anuar, HX. Ding, JWY. Tee, AL. Lee, A. Ahmad-Annuar, AH. Tan, SY. Lim (Kuala Lumpur, Malaysia)

    Objective: To describe the phenotypic continuum and genotypic spectrum of microtubule-associated protein tau (MAPT)-associated parkinsonism in a multi-ethnic Malaysian cohort. Background: Carriers of pathogenic MAPT…
  • 2026 International Congress

    Urine-derived neuronal extracellular vesicle α-synuclein seed amplification assay for synucleinopathies: a non-invasive biomarker study

    HBT. Tran, TA. Nguyen, HJ. Choi, HD. Nguyen, IH. Kwak, DG. Ko, JK. Yu, SJ. Song, JH. Lim, YE. Kim (Chuncheon, Republic of Korea)

    Objective: To investigate whether pathogenic α-synuclein can be detected using real-time quaking-induced conversion (RT-QuIC) in urine-derived neuronal extracellular vesicles (NEVs) as a fully non-invasive biomarker…
  • 2026 International Congress

    Brain-Derived Neurotrophic Factor as a Biomarker of Depression in Parkinson’s Disease

    IH. Kwak, YE. Kim, HI. Ma, JK. Yu, DG. Ko, JJ. Lee, HD. Nguyen, HBT. Tran, HJ. Choi, SJ. Song (Anyang, Republic of Korea)

    Objective: ​​​​​​To determine whether peripheral neurodegeneration-related biomarker levels differ between patients with Parkinson’s disease (PD) with and without depression and to identify biomarkers associated with…
  • 2026 International Congress

    Clinical and Functional Outcomes of Antiviral and Immunomodulatory Therapies in Subacute Sclerosing Panencephalitis

    S. Errabelly, V. Jadhav, M. Tripathi, D. Dash, P. Mohapatra, E. Arunmozhimaran (New Delhi, India)

    Objective: To evaluate whether antiviral and immunomodulatory treatments meaningfully improve true functional status and disease stabilization, or if they merely prolong survival in a state…
  • 2026 International Congress

    Botulinum toxin treatment patterns and outcomes in head and neck dystonia: experience from a tertiary, multidisciplinary clinical service

    R. Everitt, R. Aggarwal, R. Mcdonagh, C. Kobylecki (Salford, United Kingdom)

    Objective: To evaluate outcomes following Botulinum toxin (BoNT) treatment for head and neck dystonia in a tertiary multidisciplinary clinic, characterise adverse effects and identify treatment…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley